Researchers examined the original framework of the NHS Diabetes Prevention Programme (DPP) implemented in the UK.
High NfL Levels Predict Greater MS Disability Within 2 Years
Multiple sclerosis patients whose blood tests revealed elevated levels of neurofilament light chain (NfL), a biomarker of axonal damage, had worsening disability 1 to 2